@article{oai:soar-ir.repo.nii.ac.jp:00004341,
 author = {本原,  昭子 and 麻沼,  和彦 and 藤森,  実 and 土屋,  眞一 and 浜,  善久 and 丸山,  正幸 and 草間,  律 and 天野,  純},
 issue = {2},
 journal = {信州医学雑誌},
 month = {Apr},
 note = {The expression of thymidine phosphorylase (dThd Pase) in node-negative human invasive ductal carcinoma tissues was investigated by the immunocytochemical method using anti-thymidine phosphorylase monoclonal antibody.Subjects were 5 recurrent and 30 non-recurrent patients who underwent surgery at the Department of Surgery at Shinshu University Hospital between 1993 and 1996.The median follow-up period was 62.5 months.Positive dThd Pase staining was observed in the five recurrent and four non-recurrent cases. Tumor recurrence was significantly more developed in patients with dThd Pase positive staining than in those with negative staining (p＜0.01).Among the nine dThd Pase positive cases,four patients who were administered doxifluridine (5’-DFUR) or medroxyprogesterone (MPA) did not manifest recurrence. Among the recurrent patients, two were cured by oral administration of 5’-DFUR or MPA. It is suggested that the expression of thymidine phosphorylase in human breast cancer tissues may be a risk factor for tumor recurrence. The prognosis of node-negative and dThd Pase positive breast cancer patients might be improved by hormonal therapy or oral administration of 5’-DFUR., Article, 信州医学雑誌 49(2): 79-83(2001)},
 pages = {79--83},
 title = {リンパ節転移陰性乳癌組織におけるthymidine phosphorylase発現症例の検討},
 volume = {49},
 year = {2001}
}